论文信息 - Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice—Insights From the CANHEART Study - 字舞流文

Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice—Insights From the CANHEART Study

S. Goodman | J. Udell | D. Ko | A. Chu | Bing Yu | D. Tam | H. Abdel-Qadir | L. Ferreira-Legere | Maya S. Sheth | H. Abdel‐Qadir | Joan Porter | Michael E. Farkouh | Maya S Sheth